BRIEF-Mallinckrodt says first patient enrolled in phase 4 trial of H.P. Acthar gel for rare cause of nephrotic syndrome
May 17, 2016 at 16:18 PM EDT
* First patient enrolled in mallinckrodt phase 4 trial of h.p. acthar gel for rare cause of nephrotic syndrome Source text for Eikon: Further company coverage: )
